These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 10335419

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential regulation of beta3-adrenoceptors in gut and adipose tissue of genetically obese (ob/ob) C57BL/6J-mice.
    Evans BA, Papaioannou M, Anastasopoulos F, Summers RJ.
    Br J Pharmacol; 1998 Jun; 124(4):763-71. PubMed ID: 9690869
    [Abstract] [Full Text] [Related]

  • 23. Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats.
    Takeda H, Yamazaki Y, Igawa Y, Kaidoh K, Akahane S, Miyata H, Nishizawa O, Akahane M, Andersson KE.
    Neurourol Urodyn; 2002 Jun; 21(6):558-65. PubMed ID: 12382247
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [beta 3-adrenergic receptor agonists as anti-obese and anti-diabetic drugs].
    Sakura H, Togashi M, Iwamoto Y.
    Nihon Rinsho; 2002 Jan; 60(1):123-9. PubMed ID: 11808322
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
    Blachère JC, Pérusse F, Bukowiecki LJ.
    Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. New ways of insulin delivery.
    Heinemann L.
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [Abstract] [Full Text] [Related]

  • 31. Anti-obesity effects of selective agonists to the beta 3-adrenergic receptor in dogs. I. The presence of canine beta 3-adrenergic receptor and in vivo lipomobilization by its agonists.
    Sasaki N, Uchida E, Niiyama M, Yoshida T, Saito M.
    J Vet Med Sci; 1998 Apr; 60(4):459-63. PubMed ID: 9592718
    [Abstract] [Full Text] [Related]

  • 32. beta 3-Adrenergic agonist induces a functionally active uncoupling protein in fat and slow-twitch muscle fibers.
    Yoshida T, Umekawa T, Kumamoto K, Sakane N, Kogure A, Kondo M, Wakabayashi Y, Kawada T, Nagase I, Saito M.
    Am J Physiol; 1998 Mar; 274(3):E469-75. PubMed ID: 9530130
    [Abstract] [Full Text] [Related]

  • 33. [Beta 3-adrenergic receptor agonists--past, present and future].
    Takakura Y, Yoshida T.
    Nihon Yakurigaku Zasshi; 2001 Nov; 118(5):315-20. PubMed ID: 11729634
    [Abstract] [Full Text] [Related]

  • 34. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, Weber AE.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [Abstract] [Full Text] [Related]

  • 35. Anti-obesity effects of selective agonists to the beta 3-adrenergic receptor in dogs. II. Recruitment of thermogenic brown adipocytes and reduction of adiposity after chronic treatment with a beta 3-adrenergic agonist.
    Sasaki N, Uchida E, Niiyama M, Yoshida T, Saito M.
    J Vet Med Sci; 1998 Apr; 60(4):465-9. PubMed ID: 9592719
    [Abstract] [Full Text] [Related]

  • 36. Brown adipose tissue, beta 3-adrenergic receptors, and obesity.
    Lowell BB, Flier JS.
    Annu Rev Med; 1997 Apr; 48():307-16. PubMed ID: 9046964
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
    Liu X, Pérusse F, Bukowiecki LJ.
    Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032
    [Abstract] [Full Text] [Related]

  • 38. Effect of selective beta-adrenoceptor stimulation on UCP synthesis in primary cultures of brown adipocytes.
    Puigserver P, Picó C, Stock MJ, Palou A.
    Mol Cell Endocrinol; 1996 Mar 01; 117(1):7-16. PubMed ID: 8734469
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
    Bryzgalova G, Effendic S, Khan A, Rehnmark S, Barbounis P, Boulet J, Dong G, Singh R, Shapses S, Malm J, Webb P, Baxter JD, Grover GJ.
    J Steroid Biochem Mol Biol; 2008 Sep 01; 111(3-5):262-7. PubMed ID: 18621127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.